bioAffinity Technologies, Inc. (BIAF) stock
BIAFNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAFW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3071% below fair value
$2.15+0.22 (+11.40%)
Close on Nov 18, 2026Market cap $17.42MP/E –Yield –
bioAffinity Technologies price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
bioAffinity Technologies's price to sales ratio was 0.2× on Nov 11, 2026, against 0.8× a year earlier. Over the last 4 years it ranged from 0.2× to 9.1×, with a median of 1.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −0.4 |
| 2025 | Dec 31, 2025 | 0.6× | −0.7 |
| 2024 | Dec 31, 2024 | 1.3× | −0.2 |
| 2023 | Dec 29, 2023 | 1.5× | – |
See a number that looks wrong?